As with other carcinomas, Jak/STAT core components, IL-6, Jak2, and STAT5, and other key regulators of this pathway are implicated in promotion of prostate tumor growth and metastasis, and there is no highly effective treatment to cure metastatic disease. This evidence concerns the gene JAK2 and prostate neoplasm.